Back to search

Article

Anti-GD2 antibody therapy alters the neuroblastoma tumor microenvironment and extends survival in <i>TH-MYCN</i> mice

2021-06-10

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Neuroblastoma is a commonly lethal solid tumor of childhood and intensive chemoradiotherapy treatment cures ~50% of children with high-risk disease. The addition of immunotherapy using dinutuximab, a monoclonal antibody directed against the GD2 disialoganglioside expressed on neuroblasts, improves survival when incorporated into front-line therapy and shows robust activity i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ae8d7e23-64c3-542c-ad4f-8d78a1f62efe
DOI
10.1101/2021.06.09.447746
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anti-GD2 antibody therapy alters the neuroblastoma tumor microenvironment and extends survival in <i>TH-MYCN</i> miceDOI 10.1101/2021.06.09.447746
Select a neighboring publication to make it the new centre.